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elderly are limited in literature. This study, therefore, aimed to evaluate the pre-
scription pattern specifically among Indian elderly patients using WHO prescrib-
ing indicators.
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Objectives: The aim of this study is to determine the main causes of the dynamics 
of outpatient drug expenditures in Austria on an aggregate view (ATC level 1) over 
the last 10 years and to identify the key factors for the current developments at a 
more detailed, therapeutic level. MethOds: The data comprise the filled prescrip-
tions at the expense of all statutory health insurance funds in Austria, covering 
more than 97% of the national population. Observation period is from 2005 to 2014, 
with a preview of 2015. Year-on-year changes are calculated at different ATC levels. 
Costs are in euros excluding VAT. Results: Pharmaceutical expenditures increased 
significantly from 2005 until 2008, while from 2009 to 2013 there were only moderate 
increases. In 2014, expenditures started to rise considerably again, the ATC groups J 
(antiinfectives), L (antineoplastics and immunomodulators), and B (blood and blood 
forming organs) practically being the sole causes. One steady development over 
the last 10 years is the constant cost increase in the group L. Group N (nervous 
system) was the second cost driver until 2011, but faded afterwards. Beginning 
with 2012, group B is one of the major cost drivers. There are recently no significant 
cost declines through losses of exclusivity, except for the year 2013. Looking more 
into detail, one can observe that the current rise is strongly dominated by the new 
hepatitis c drugs (part of group J), followed by direct oral anticoagulants (DOACs, 
part of group B). cOnclusiOns: The new hepatitis c drugs are the main cause for 
the current increases in public outpatient pharmaceutical expenditures in Austria. 
As there are no remarkable compensating savings via generic entries, the cost rise 
poses a severe challenge for the public health insurance system, especially amid 
continuing weak economic growth and therefore stressed health budgets.
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Objectives: To assess drug use pattern in outpatient departments (OPDs) 
of two tertiary care hospitals (Bahawal Victoria Hospital and Civil Hospital) of 
Bahawalpur, Pakistan. MethOds: This was a descriptive, non-experimental and 
cross-sectional study. For the prescribing indicators, 2,400 prescriptions (10 OPDs 
per hospital, 120 prescriptions per OPD) were systematically sampled out of the 
total 1,560, 000 prescriptions written during April 2014 to March 2015. A total of 600 
randomly selected patients (300 patients per hospital, 30 per OPD) and all pharma-
cists available in both hospitals were interviewed to investigate the patient-care 
and facility-specific indicators. We used published ideal standards for each of the 
WHO/INRUD indicators. Results: Among the prescribing indicators, the average 
number of drugs per encounter was 2.8 (SD = 1.3) (optimal value = 1.6–1.8), the 
drugs prescribed by generic name were 56.6% (optimal value = 100%), the encoun-
ters with an antibiotic prescribed were 51.5% (optimal value = 20.0–26.8%), the 
encounters with an injection prescribed were 0.0% (optimal value = 13.4–24.1%) 
and the drugs prescribed from Essential Drugs List (EDL) were 98.8% (optimal value 
= 100%). Among the patient-care indicators, the average consultation time was 
1.2 minutes (SD = 0.8) (optimal value ≥ 10 minutes), the average dispensing time 
was 8.7 seconds (SD = 4.9) (optimal value ≥ 90 seconds), the percentage of drugs 
actually dispensed was 97.3% (optimal value = 100%), the percentage of drugs 
adequately labeled was 97.3% (optimal value = 100%) and the patients’ knowledge 
of correct dosage was 61.6% (optimal value = 100%). Among the facility-specific 
indicators, both health care facilities had a copy of EDL and key drugs available 
in the stock were 72.4% (optimal value = 100%). cOnclusiOns: Irrational use of 
drugs was observed in both health care facilities. Continuous education of the 
physicians, increased physician-to-patient and pharmacist-to-patient ratio are 
some options to promote rational drug use.
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Objectives: Systematic literature reviews (SLRs) play an important role in 
evidence-based medicine and are increasingly favored over traditional narra-
tive reviews as a method to objectively summarize vast amounts of outcomes 
data. Our objective was to evaluate a cross-section of published SLRs in oncol-
ogy and determine the top journals, main purposes, meta-analysis frequency, 
and sponsorship. MethOds: Searches were conducted in Embase and MEDLINE 
for the year 2014 and further restricted to cancer topics. Case reports, editori-
als, conference abstracts, and letters were excluded. Abstracts were manually 
reviewed to identify SLRs, published in journals, and reporting oncology drug 
therapy. Results: A total of 1,510 unique citations were identified; 727 were 
determined to be SLRs in oncology. 9 SLRs included case reports describing rare 
cancers or adverse drug reactions. Drug therapy was noted in 391 publications 
(53.8%); 210 included meta-analysis. Journals publishing the largest number of 
SLRs were PLoS ONE (n= 30), Tumor Biology (n= 17), Cancer Treatment Reviews 
(n= 15), World Journal of Gastroenterology (n= 10) and Journal of Clinical Oncology 
(n= 9). Impact factors for these journals ranged from 2.369 to 17.879. Most fre-
quent purposes were treatment comparisons (27.9%), efficacy assessments (15.6%), 
17%). Considering the disease treatment distribution, 857 patients were treated for 
rheumatoid arthritis (28,55%), 811 for psoriatic arthritis (27,02%), 421 for psoria-
sis (14,02%) and remaining patients for other diseases (i.e. ankylosing spondylitis, 
ulcerative colitis) . 86 patients (25.8%) switch biologic therapy within the first 120 
days, 97 patients (29.22%) between 120 and 210 days, 82 patients (24.70%) between 
210 and 300 days, 67 patients (20, 18%) between 300 and 365 days. cOnclusiOns: 
The present study is able to provide a map of the current strategy of treatment 
with biologics in the region Lazio considering medical conditions and prescribed 
treatments.
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Objectives: To understand the full impact of a novel treatment, particularly in 
more subjective symptoms such as pain, capturing information on any additional 
medication a patient may have taken alongside the study drug is vital. Two major 
challenges to the accurate recording of this data in global clinical trials have been 1) 
producing “localisations” of concomitant medications that are applicable and com-
parable in all countries involved in the study; and 2) moving away from a reliance on 
retrospective, site-based capture from patients. The aim of this study was to develop 
and document an easy to use electronic diary solution combined with an appropri-
ately localised medication list. MethOds: An electronic medication diary which 
allowed for the recording of medication name, route of administration and dosage 
was developed for a handheld platform, with iterative testing and refinement in 
users. The solution included a pre-populated, tailored list of the patient’s most com-
mon drugs (n = 38), which could be localised on a country-by-country basis (n = 21) 
following a process for ensuring the appropriateness of the drug name in the local 
market. Results: The iterative approach to design and development ensured the 
development of an electronic solution which was user-friendly and intuitive. Over 
3 rounds of testing a number of updates were made based on feedback from user 
relating to the flow of the diary and the training module. Best practice for developing 
appropriate localised list of concomitant medication involved asking two local 
experts for feedback using in-country medical databases. cOnclusiOns: Accurate 
tracking of concomitant medication usage is an important aspect of assessing the 
effectiveness of a new treatment. A user-focused electronic diary solution over-
comes the limitations of traditional, retrospective approaches to capturing this 
information. Localisation of the concomitant drug list ensures accurate and com-
parable data captured across all studies in a trial.
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Objectives: This study aimed to evaluate the Prevalence and Perception Use of 
Non-Prescription medicines (NPM) among medical undergraduate students (i.e. 
from pharmacy, MBBS and nursing students) in Quetta, Pakistan. MethOds: A 
cross-sectional study was conducted by using self-administered questionnaire, 
which consists of 15 questions. Medical students i.e. pharmacy, MBBS and nursing 
students were included in the study from different institutes providing the medi-
cal education. he descriptive statistics (frequencies and percentage) was used to 
present the data . All analyses were performed using SPSS 20.0. Results: A total 
of 300 questionnaires were distributed and 260 were returned (Response rate of 
86.7%). Among 260 respondents females were 164 (63.1%). Majority of participants 
246 (94.6%) knew about Non-Prescription medicines (NPM), 240 (92.3%) were used 
NPM drugs and 228 (87.7%) purchases NPM easily form the pharmacies. one hundred 
and forty (53.8%) respondents know about contraindication of NPM drugs while 205 
(78.8%) recommended the use of NPM to friend and relatives. The major use of NPM 
is to relief ache, pain and other condition such as cough, cold, fever, diarrhea, dys-
menorrhea constipation, vomiting and flu etc. cOnclusiOns: This study showed 
that majority of the Medical students were aware of different non-prescription 
medicines and their use and high prevalence is present among medical student to 
use these NPM for minor illness.
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Objectives: Studies on the characterization of prescription among Indian elderly 
are limited in literature. This study, therefore, aimed to evaluate the prescription 
pattern specifically among Indian elderly patients using WHO prescribing indi-
cators. MethOds: Prescriptions of 4005 outpatients, age 60 yrs or above, were 
evaluated prospectively using WHO prescribing indicators. Results: The aver-
age age (±SEM) of patients was 68.28±0.11 yrs. On an average, each patient had 
2.01±0.01 diagnoses & was prescribed 6.45±0.04 drugs. The most common disorder 
was ‘Diseases of circulatory system”. The patients were prescribed an average of 
6.45±0.04 medications. Over half of the patients (57.9%) received more than five 
medications concurrently. The percentage of drugs prescribed by generic name 
was only 0.8%. Antibiotic usage was 13% while 7.3% of patients were prescribed 
injections. The percentage of drugs prescribed from National List of Essential 
Medicines 2003 was 66% of the drugs prescribed. cOnclusiOns: The minimal 
prescription of antimicrobials and injections coupled with higher prescriptions 
from essential drug list is a very positive reflection of good prescribing among 
elderly outpatients. Studies on the characterization of prescription among Indian 
